Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Unihealth Hospitals's annualized ROCE % for the quarter that ended in Mar. 2026 was 25.32%.
Unihealth Hospitals (NSE:UNIHEALTH) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
Unihealth Hospitals ROCE % Related Terms
Unihealth Hospitals ROCE % Historical Data
* Premium members only.
The historical data trend for Unihealth Hospitals's ROCE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
(1) Note:
The EBIT data used here is one times the annual (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Unihealth Hospitals (NSE:UNIHEALTH) has a ROCE % of 25.32% as of Mar. 2026.
Is Unihealth Hospitals' ROCE % too high?
Unihealth Hospitals' current ROCE % is 25.32%. The Healthcare Providers & Services industry median ROCE % is 6.63. Unihealth Hospitals' value of 25.32% is 281.9% above this industry median. Overall, Unihealth Hospitals has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Unihealth Hospitals' ROCE % compare to HCA and THC?
Unihealth Hospitals' ROCE % of 25.32% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.63. Unihealth Hospitals' value of 25.32% is 281.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.63, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Unihealth Hospitals's current ROCE % of 25.32% is 281.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Unihealth Hospitals's current ROCE % is 25.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unihealth Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Unihealth Hospitals (NSE:UNIHEALTH) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹385.86, compared to a current price of ₹751.10 — trading 94.7% above its estimated fair value. The current ROCE % is 25.32% and 281.9% above the Healthcare Providers & Services industry median of 6.63. Unihealth Hospitals' overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Unihealth Hospitals (NSE:UNIHEALTH), the current ROCE % is 25.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Unihealth Hospitals (NSE:UNIHEALTH) Overvalued in 2026?
Based on GuruFocus' analysis, Unihealth Hospitals stock appears to be overvalued.
The current stock price of ₹751.10 is trading 94.7% above its estimated GF Value™ of ₹385.86.
GuruFocus considers Unihealth Hospitals to be Significantly Overvalued.
Key valuation signals for NSE:UNIHEALTH:
ROCE %: 25.32%
GF Value™: ₹385.86 vs. price of ₹751.10 (94.7% above fair value)
Industry Position: 281.9% above the Healthcare Providers & Services median
No single metric tells the full story. See the NSE:UNIHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Unihealth Hospitals Ltd is a healthcare service provider based out of India and has an operational presence in multiple countries across the African continent. The company is predominantly engaged in the business of medical tour operators, health consultancy services, and also trades in medical equipment. The company has only one reportable Business Segment, which is Healthcare Services and Trading in its related products. Geographically, the company derives revenue from India, Uganda, Tanzania, Nigeria, the UAE, and Mauritius.
59GF Score
Get the complete analysis for NSE:UNIHEALTH
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:UNIHEALTH has been successfully added to your 
